Yazar "Arat, Mutlu" için listeleme
-
Peripheral blood stem cell collection for allogeneic hematopoietic stern cell transplantation: Practical implications after 200 consequent transplants
Sahin, Deniz Goren; Arat, Mutlu (PERGAMON-ELSEVIER SCIENCE LTD, 2017)Background: Proper stem cell mobilization is one of the most important steps in hematopoietic stem cell transplantation (HSCT). The aim of this paper is to share our 6 years' experience and provide practical clinical ... -
RISK FACTORS INFLUENCING TRANSPLANT OUTCOMES OF ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN FIRST COMPLETE REMISSION: A RETROSPECTIVE ANALYSIS FROM THE ALWP OF THE EBMT
Calabro, Martina; Labopin, Myriam; Battipaglia, Giorgia; Arat, Mutlu; Yakoub-Agha, Ibrahim; Salmenniemi, Urpu; Vydra, Jan (Springernature, 2023)[Abstract Not Available] -
A survey of hematologists on compulsory health service in Turkey
Yeğin, Zeynep Arzu; Arat, Mutlu (Galenos Yayınevi, 2011)The quality of health care is closely related to the level of physician job satisfaction, which depends on several factors, including working conditions, income, hospital resources and workload [1-3]. Compulsory health ... -
Ulusal Gönüllü Kök Hücre Verici Bankası (TÜRKÖK) Kurulması Akraba Dışı Hematopoietik Kök Hücre Nakli Etkinliğimizi Nasıl Etkiledi? Geriye Dönük Tek Merkez Değerlendirmesi
Amaç: Allojeneik hematopoietik kök hücre nakli (AHKHN) erişkin hematolojik malignitelerde tedavi edici bir hücresel yöntemdir. Türkiye Kök Hücre Koordinasyon Merkezi (TÜRKÖK), 2015 yılında T.C. Sağlık Bakanlığı tarafından ... -
Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi study
Arat, Mutlu; Alacacioglu, Inci; Bolaman, Ali Zahit; Buyukasik, Yahya; Cagirgan, Seckin; Guvenc, Birol; Kaya, Emin (Future Medicine Ltd, 2023)Aim: To determine the unmet needs and challenges in management, diagnosis, treatment, follow-up and patient-physician communication in acute leukemia (AL). Materials & methods: The study was based on a modified Delphi ... -
The use of second allogeneic hematopoietic stem cell transplantation for hematologic malignancies relapsed after the first: Does it worth to do?
Goksoy, Hasan Sami; Arat, Mutlu (PERGAMON-ELSEVIER SCIENCE LTD, 2016)Allogeneic (allo) hematopoietic stem cell transplantation (HSCT) is the only curative option for many malignant and benign hematological disorders. It seems hopeless for patients who relapse after this strategy. In the era ...